Skip to main content
CRL logo

CRL · Charles River Laboratories International, Inc. · Debt

Track CRL — free
$337.54 -2.12 (-0.62%)
Market Cap
$16.21B
Shares
47.74M
Volume · Oct 23 18.17K Avg daily vol (3M) 1M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Latest reported total
USD 2,100,000,000
As of Dec 27, 2025
Tracked instruments
0
Loans, facilities and note series
Annual baseline
Dec 27, 2025
Latest approved annual total
Reported total debt history
As of Reported label Amount Source
2025-12-27 debt and finance leases USD 2,100,000,000 10-K filed 2026-02-18
As of December 27, 2025, we had $2.1 billion of debt and finance leases (debt).

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current long-term debt and lease obligations 2026-06-27 USD 6,626,000 10-Q filed 2026-08-05
Current portion of long-term debt 2026-06-27 USD 5,460,000 10-Q filed 2026-08-05
Finance lease liabilities 2026-06-27 USD 9,848,000 10-Q filed 2026-08-05
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 1,166,000
Noncurrent long-term debt and lease obligations 2026-06-27 USD 2,619,985,000 10-Q filed 2026-08-05
Noncurrent operating lease liabilities 2026-06-27 USD 407,708,000 10-Q filed 2026-08-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1100682 CUSIP 159864107 13F (30d) 107 filings 100 filers Visit website Investor relations